ED, US HP Therapeutic Area Communication Job Details | BoehringerPRD

ED, US HP Therapeutic Area Communication

Description

The Executive Director, US HP Therapeutic Area Communications will lead an integrated brand function for US HP, setting the vision and strategy across products and therapeutic areas. This role will serve as a senior Corporate Affairs leader who brings a holistic US perspective spanning brand communications, external environment, policy and government affairs. The position holder will ensure all communications advance business priorities, strengthen reputation and are aligned with US strategy.

The ED, US HP Therapeutic Area Communications will represent US Corporate Affairs perspective on the Human Pharma Leadership Team (HPLT) and sits on the US Corporate Affairs Leadership Team.

As an employee of Boehringer Ingelheim, you will actively contribute to the discovery, development, and delivery of our products to our patients and customers. Our global presence provides an opportunity for all employees to collaborate internationally, offering visibility and the opportunity to directly contribute to the company's success. We realize that our strength and competitive advantage lie with our people. We support our employees in several ways to foster a healthy working environment, meaningful work, mobility, networking, and work-life balance. Our competitive compensation and benefit programs reflect Boehringer Ingelheim's high regard for our employees.

Compensation Data

The base salary range for this role is $250,000 to $394,000. The position may be eligible for a role specific discretionary bonus, relocation, and/or other compensation elements.  We continuously review market data and may adjust salary ranges as needed in the future.  Actual compensation will be based on job-related factors such as skills, experience, and qualifications, and other factors permitted by law.

Duties & Responsibilities

Requirements

Eligibility Requirements:

Our Company

Boehringer Ingelheim is a biopharmaceutical company active in both human and animal health. As one of the industry’s top investors in research and development, the company focuses on developing innovative therapies that can improve and extend lives in areas of high unmet medical need. Independent since its foundation in 1885, Boehringer takes a long-term perspective, embedding sustainability along the entire value chain. Our approximately 54,300 employees serve over 130 markets to build a healthier and more sustainable tomorrow.